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AChR is concentrated at the postjunctional membrane at the neuromuscular junction. However,
the underlying mechanism is unclear. We show that α-actinin, a protein known to cross-link F-
actin, interacts with rapsyn, a scaffold protein essential for neuromuscular junction formation. α-
Actinin, rapsyn, and surface AChR form a ternary complex. Moreover, the rapsyn-α-actinin
interaction is increased by agrin, a factor known to stimulate AChR clustering. Downregulation of
α-actinin expression inhibits agrin-mediated AChR clustering. Furthermore, the rapsyn-α-actinin
interaction can be disrupted by inhibiting Abl and by cholinergic stimulation. Together these results
indicate a role for α-actinin in AChR clustering.
Background
The concentration of nicotinic acetylcholine (ACh) recep-
tors (AChRs) directly apposed to motoneuron terminals
ensures the fast and efficient transmission from the nerve
to the muscle. This concentration in the adult muscle fiber
membrane results in an AChR density of 10,000 per
micron at the postsynaptic membrane dropping to less
than 10 per micron just a few micrometers away from the
neuromuscular junction (NMJ) [1,2]. This is generated by
complex interactions between motoneuron terminals and
skeletal muscles [3-6]. Neural agrin clusters AChRs via
activating the receptor complex consisting of LRP4 and
MuSK [7-11], both of which are essential for NMJ forma-
tion [8,12]. ACh is thought to disassemble receptor clus-
ters in non-synaptic areas via activating muscle fibers [13-
15].
Rapsyn (for receptor-associated protein at synapse) is an
intracellular peripheral protein that precisely co-localizes
with the AChR [16-18]. Rapsyn is present at or greater
than a 1:1 ratio with the AChR [19-21], and is believed to
anchor AChRs at the synapse [18,21-26]. Recent studies
suggest a multi-facet role of rapsyn in AChR clustering. It
has been shown to interact with several proteins including
the AChR [16-18,27], β-dystroglycan [28,29], actin [30],
and β-catenin [31]. It is believed that these interactions
bridge AChRs to the cytoskeleton. On the other hand, rap-
syn prevents the activation of Cdk5, a kinase downstream
of the negative signal ACh to disperse AChR clusters [32].
Using a proteomic approach to identify proteins that spe-
cifically associated with clustered surface AChR, we dis-
covered a critical role of HSP90beta in AChR clustering by
stabilizing rapsyn [33].
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To further study rapsyn's role we performed a yeast two-
hybrid screen with rapsyn as bait. One protein we found
was α-actinin, an actin cross-linker. To study the possible
role of α-actinin in AChR clustering, we carried out a
number of experiments to characterize the interaction
between α-actinin and rapsyn. We also investigated the
consequences of suppressing α-actinin expression on
AChR clustering. Finally, we looked at two factors that are
known to disrupt agrin regulated AChR clustering to
determine if they negatively regulate the rapsyn-α-actinin
interaction. Results of these studies indicate a role for α-
actinin in agrin-induced AChR clustering.
Results
Rapsyn and α-actinin interact and colocalize
To identify cytoskeletal proteins that may interact with
rapsyn, we used the yeast two-hybrid system. A screen of a
mouse cDNA library [34] using full length rapsyn as the
bait found α-actinin. To determine which rapsyn domains
were important for the interaction with α-actinin, we gen-
erated a number of rapysn mutants. Rapsyn has eight
tetratricopeptide repeats (TPRs) (amino acids 6–319), a
coiled-coil domain (amino acids 298–331), and a
cysteine-rich domain (amino acids 363–402) [26,35]. The
TPR domains are responsible for rapsyn self association;
while the coiled-coil domain is required for AChR cluster-
ing and interacts with the AChR β-subunit cytoplasmic
domain (reviewed by Banks et al., 2003)[36]. Hence, we
generated rapsyn constructs lacking the ring domain, the
coiled-coil domain and the TPR domain, and a construct
that only included a few of the TPR domains. Constructs
lacking the coiled-coil domain could not bind α-actinin,
suggesting that this domain is required for interacting
with  α-actinin; however, the coiled-coil domain alone
could not bind α-actinin, indicating that this region is not
sufficient for the interaction (Fig. 1A).
Previous studies have shown that certain hydrophobic res-
idues within rapsyn's coiled-coil domain were required
for the protein's interaction with the AChR [27]. To
explore which amino acids in the coiled-coil domain may
be important for binding α-actinin, we generated a
number of mutants in which four amino acids at a time
were mutated to cysteine. Cotransformation of these
mutants along with α-actinin into yeast cells showed that
a number of regions within the coiled-coil domain were
important in rapsyn's interaction with α-actinin. Specifi-
cally, amino acids 309–316 and amino acids 321–324
were required for the interaction (Fig. 1B). Hence, the
coiled-coil domain is not only required for binding the
AChR but is also important in rapsyn's interaction with α-
actinin. Furthermore, the region that binds α-actinin
included both hydrophobic and hydrophilic residues,
indicating the region for α-actinin may be broader than
that for AChR β-subunit [27].
Next, we identified which regions of α-actinin interact
with rapsyn and whether or not the interaction was direct.
α-Actinin forms anti-parallel dimers with an actin binding
head, followed by four spectrin repeats leading to a cal-
modulin like domain comprising two EF hand repeats
(reviewed by Otey and Carpen)[37]. Using a number of α-
actinin mutants, we found that a linker region between
the last spectrin domain and the first EF1 hand (amino
acids 741–757) was required for the interaction with rap-
syn in yeast cells (Fig. 1C). To confirm the finding, we gen-
erated a battery of α-actinin GST-fusion proteins and
incubated the immobilized proteins with lysates of cells
expressing HA-rapsyn. Bound rapsyn was probed with
anti-HA antibodies. As shown in Fig. 1D, GST-fusion pro-
tein containing amino acids 653–824 interacted with HA-
rapsyn, in agreement with observations from yeast stud-
ies. To determine whether the rapsyn-α-actinin interac-
tion was direct, not via a third protein, α-actinin GST
fusion proteins were incubated with [35S]-labeled rapsyn
generated by in vitro translation. Again, [35S]-rapsyn
bound to GST-α-actinin 653–824, but not the parental
GST or α-actinin 751–824 (Fig. 1E). These results indi-
cated that the two proteins directly bind to each other,
and provide further evidence that the binding region in α-
actinin is localized in a region between amino acids 653–
751. Numerous studies have established that rapsyn pre-
cisely colocalizes with AChRs at the NMJ. Previous reports
have also found that α-actinin and AChRs colocalize and
associate at the NMJ [38,39]. Similarly, staining of mouse
diaphragm sections with antibodies specific for α-actinin
and rapsyn indicated colocalization between the two pro-
teins (Fig. 2A).
The rapsyn-α-actinin interaction is regulated by agrin
To determine whether rapsyn and α-actinin interact in
mammalian cells, we cotransfected GFP-α-actinin with
Myc-rapsyn, Myc-calsarcin (a known α-actinin binding
partner [40]) or Myc-empty vector into HEK 293 cells.
Immunoprecipitation of Myc-rapsyn resulted only in a
weak coprecipitation of α-actinin, compared to calsarcin
(Fig. 2B). Next we studied the rapsyn-α-actinin interaction
by immunoprecipitating C2C12 myotubes with anti-rap-
syn antibody and probing the precipitates for α-actinin.
Similar to the results in HEK 293 cells, we only saw a weak
association between the two proteins in untreated C2C12
cells. This led us to question whether the interaction may
be regulated by agrin. Remarkably, when myotubes were
stimulated with agrin for 18 hr that induce AChR cluster-
ing (Fig. 2C), we found a significant increase in coprecip-
itation between rapsyn and α-actinin (Fig. 2D and 2E).
The interaction was increased about 6–10 fold in agrin-
treated muscle cells, suggesting that agrin stimulates the
rapsyn-α-actinin interaction.Molecular Brain 2008, 1:18 http://www.molecularbrain.com/content/1/1/18
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Rapsyn is required for the AChR-α-actinin interaction
The agrin-regulated rapsyn-α-actinin interaction does not
necessarily imply that the AChRs also interact with α-
actinin in an agrin-dependent manner. We used biotin-
conjugated α-bungarotoxin (B-BTX) to pull down AChRs
from C2C12 myotubes treated and untreated with agrin.
Similar to the previous experiment, we found a significant
increase in the AChR-α-actinin interaction following agrin
stimulation (Fig. 3A and 3B).
The AChR-α-actinin interaction could be direct or medi-
ated through another protein. To determine if the agrin
regulated AChR-α-actinin interaction was dependent on
rapsyn, control myotubes and rapsyn -/- myotubes were
stimulated with agrin for 18 hr and AChRs were isolated
as before. Interestingly, no α-actinin was detectable asso-
ciated with AChRs in rapsyn -/- cells, unlike control myo-
tubes (Fig. 3C), indicating that rapsyn is required for the
AChR-α-actinin interaction. These results suggest that the
α-actinin binding site in rapsyn may not overlap or inter-
fere with that for AChRs and that α-actinin, rapsyn, and
AChR may form a ternary complex upon agrin stimula-
tion.
A role for α-actinin in AChR clustering
To investigate whether α-actinin is involved in AChR clus-
tering, we used a micro-RNA (miRNA) approach to sup-
press its expression. Multiple double stranded oligo
duplexes were designed targeting a number of regions
toward  α-actinin 2; miRNA-actinin791 in particular
showed a substantial reduction of α-actinin 2 expression
(Fig. 4A). We transfected this miRNA construct into myo-
tubes and characterized agrin-induced AChR clusters.
Transfected myotubes were labeled by GFP encoded by
the parental miRNA construct. Compared to the control
miRNA vector, we saw a significant reduction in AChR
clusters in myotubes transfected with miRNA-actinin791
(Fig. 4B and 4C). Over-expression of α-actinin, however,
had no influence on AChR clustering, probably because α-
actinin is saturated in vivo.
Abl represents a family of tyrosine kinases that among
other functions regulate actin structure. They are localized
at the NMJ, undergo reciprocal tyrosine phosphorylation
with MuSK, and are required for agrin mediated AChR
clustering [41]. We hypothesized that the rapsyn-α-
actinin interaction is downstream of Abl and thus regu-
lated by this tyrosine kinase. Hence, if the rapsyn-α-
actinin interaction is important for AChR clustering,
inhibiting Abl should disrupt the interaction. To test this
hypothesis, myotubes were treated with agrin in the pres-
ence of STI-571, a specific inhibitor of Abl [41-43]. As pre-
viously reported [41], we found a significant reduction by
STI-571 in the number of agrin-induced AChR clusters
(data not shown). Intriguingly, the Abl inhibitor signifi-
cantly reduced the rapsyn-α-actinin interaction (Fig. 5A
and 5B).
Recent studies have shown that ACh and agrin play con-
trasting roles in shaping AChR clusters; agrin appears to
offset ACh's dispersal mechanism [14,44,45]. To deter-
mine whether the rapsyn-α-actinin interaction is regu-
lated by muscle activation, myotubes were first treated
with agrin overnight, washed, and stimulated with carba-
chol, a non-hydrolysable cholinergic agonist, at 10 μM for
4 hr. As previously described, this treatment resulted in a
dramatic reduction in the number of clusters (data not
shown) [14,45,46]. Remarkably, there was a dramatic
decrease in the rapsyn-α-actinin interaction in myotubes
treated with carbachol.
Discussion
In this study we find that α-actinin interacts with rapsyn;
and the interaction was regulated by agrin. We also find
that AChR, rapsyn, and α-actinin form a ternary complex
that is also up-regulated by agrin. Furthermore, downreg-
ulating  α-actinin expression inhibits agrin-mediated
α-Actinin interacts with rapsyn Figure 1 (see previous page)
α-Actinin interacts with rapsyn. (A) Y190 cells were cotransformed with pGBT10-rapsyn and rapsyn mutants along with 
pACT2-α-actinin. Transformed yeast cells were seeded in Leu-Trp-His- plates and scored for β-gal activity: (-) no blue after 8 
hr, (+) blue after 2 hr. The coiled-coil domain of rapsyn was required for its interaction with α-actinin. (B) Four amino acids at 
a time were mutated to cysteine starting at the beginning of rapsyn's coiled-coil domain. The mutants were then subcloned into 
pGBT10 and cotransformed into yeast cells with pACT2-α-actinin. Transformed yeast cells were seeded in Leu-Trp-His- plates 
and scored as in (A). Amino acids 309–316 and amino acids 321–324 within the coiled-coil domain were necessary for rapsyn's 
interaction with α-actinin. (C) pGBT10-raspyn was cotransformed with the pACT2-α-actinin constructs into yeast. A linker 
region composing amino acids 741–757 was required for the interaction with rapsyn. (D) α-Actinin GST-fusion proteins immo-
bilized on glutathione sepharose 4B beads were incubated with lysates from HEK 293 cells transfected with HA-rapsyn. Bead-
associated proteins were subjected to SDS-PAGE and immunoblotting (IB) with indicated antibodies. (E) [35S]-labeled rapsyn 
was generated by in vitro translation in the presence of [35S]-labeled methionine and incubated with bead-immobilized GST-α-
actinin. Bound [35S]-labeled proteins were resolved on SDS-PAGE and subjected to autoradiogram. GST α-actinin (653–824) 
interacted directly with rapsyn.Molecular Brain 2008, 1:18 http://www.molecularbrain.com/content/1/1/18
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AChR clustering. Finally, we show that the rapsyn-α-
actinin interaction can be disrupted by inhibiting Abl and
by cholinergic stimulation. These results identify a role for
α-actinin in agrin-induced AChR clustering.
α-Actinin is an important scaffolding protein known to
cross-link F-actin. It forms head-to-tail dimmers via spec-
trin-like repeats creating a long molecule with actin bind-
ing domains at each end which cross-link actin filaments.
In dendritic spines of hippocampal neurons, α-actinin has
been found to interact directly with NMDA receptors,
anchoring them to the underlying F-actin [47]. Also, α-
actinin is thought to play a role in the formation and
transport of AMPA receptors to the dendritic spines [48].
Our results indicate that the region responsible for α-
actinin's interaction with rapsyn is within a linker region
at the C terminus of the spectrin repeats. This finding is
consistent with other studies that have mapped the
importance of the spectrin domains and linker region in
protein docking (reviewed by Otey and Carpen) [37]. α-
Actinin has been shown to associate with AChRs in skele-
tal muscle [39]. We further characterize this association by
isolating AChRs with B-BTX and probing for α-actinin. As
with the rapsyn-α-actinin interaction, α-actinin is mini-
mal in the AChR complex pulled down from untreated
myotubes but is significantly increased in myotubes
treated with agrin. The similarity between the agrin regu-
lation of the rapsyn-α-actinin interaction and the AChR-
α-actinin interaction strongly suggests that the AChR-α-
actinin interaction is dependent on rapsyn. The fact that
AChRs isolated from rapsyn -/- myotubes showed no
interaction with actinin further supports the idea that rap-
syn serves as a bridge between the AChRs and the cytoskel-
etal protein.
Abl has been implicated in AChR clustering, presumably
downstream of MuSK. MuSK and Abl undergo reciprocal
tyrosine phosphorylation upon agrin stimulation that is
required for AChR clustering [41]. Abl is thought to be
upstream of the Rho family of small GTPases [49,50]. Rac,
Rho and Cdc 42 have all been shown to play a potentially
important role in AChR clustering [51-53]. Results suggest
that these proteins switch on actin polymerization, bring-
ing actin to the site and or changing actin already at the
site to aid AChR anchoring. We hypothesize that α-actinin
is a regulatory scaffolding protein for the rapsyn-AChR
complex, and may aid in this important cytoskeletal link.
When Abl is inhibited, α-actinin losses its ability to inter-
act with rapsyn in response to agrin stimulation. Consist-
ently, activation of muscles by cholinergic agonist CCh
disrupts the rapsyn-α-actinin interaction. Hence, the
interaction is regulated by both positive, agrin, and nega-
tive, ACh, signals and may in part represent an important
junction in AChR clustering.
How might the rapsyn-α-actinin interaction be control-
led? Tyrosine kinases have been shown to regulate α-
actinin's interaction with other proteins [54]. Agrin activa-
tion may lead to the phosphorylation of α-actinin, upreg-
ulating its interaction with rapsyn. This could work in
tandem with actin modulation creating a scaffold for
anchoring the rapsyn-AChR complex at the site of agrin
deposition. Conversely, ACh may have the opposite
effect. Studies suggest that ACh may mediate its dispersal
effects through the serine-threonine kinase cdk5. Interest-
ingly though, cdk5 is known to bind α-actinin [55]. An
attractive hypothesis is that cdk5 is bound to α-actinin
until agrin release results in a change of α-actinin binding
partners from cdk5 to rapsyn. Alternatively, the rapsyn-α-
actinin interaction could be regulated by a protein tyro-
sine phosphatase. There is evidence that AChR clustering
and declustering are dependent on tyrosine kinases and
phosphatses respectively [41,56-59]. Shp2 is concentrated
at the NMJ [60] and has been implicated in AChR disper-
sal [56]. However, mutant mice that do not express Shp2
in muscle cells form apparently normal NMJs, suggesting
that this phosphatase may be dispensable for NMJ forma-
tion and/or maintenance [61]. Interestingly, Shp1 has
been found to be a phosphatase for α-actinin [62].
Whether Shp2 regulates AChR clustering or NMJ forma-
Regulation of the rapsyn-α-actinin interaction by agrin Figure 2 (see previous page)
Regulation of the rapsyn-α-actinin interaction by agrin. (A) Colocalization of α-actinin and rapsyn. Cross sections of 
adult mouse diaphragm were costained with antibodies specific for α-actinin and rapsyn. α-Actinin and rapsyn immunoreactiv-
ity was visualized by FITC and Cy3 conjugated secondary antibodies, respectively. (B) HEK 293 cells were cotransfected with 
GFP-α-actinin, Myc-calsarcin, Myc-rapsyn or Myc empty vector. Cell lysates were incubated with anti-Myc antibody followed 
by protein G agarose beads. Resulting precipitates were probed by indicated antibodies. (C) Ability of agrin to stimulate AChR 
clustering. C2C12 myotubes were stimulated without (control) or with 10 ng/ml agrin for 18 hr, and stained with Alexa 594-
conjugated α-BTX. (D) Increased interaction in agrin-stimulated C2C12 myotubes. Lysates of control and stimulated myotubes 
were incubated with a rapsyn specific antibody followed by protein A agarose beads. After separation by SDS-PAGE and mem-
brane transfer, immunoblotting was carried out with an antibody specific to α-actinin. Percentage of lysate inputs was immuno-
blotted to quantify the immunoprecipitation. (E) Quantitation of blot. The amount of α-actinin interacting with rapsyn is 
significantly greater upon agrin treatment. Data represent mean ± SEM of three experiments. **, p < 0.01, two-tailed Student's 
paired t test.Molecular Brain 2008, 1:18 http://www.molecularbrain.com/content/1/1/18
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tion remains unclear because this phosphatase is enriched
in heamopoitic cells.
Finally,  α-actinin is enriched and concentrated in the
postsynaptic density (PSD) of excitatory synapses in den-
dritic spines [47,63,64]. Here it binds NMDA and AMPA
receptors and other PSD proteins linking them to the
underlying actin cytoskeleton [48,65-67]. We have shown
that the rapsyn-α-actinin interaction can be regulated by
both positive and negative receptor clustering signals rais-
ing the possibility that α-actinin has a similar function in
the PSD.
Methods
Reagents, constructs and antibodies
α-Actinin and mutant yeast constructs were subcloned
into pACT2 or into pGEX-2T. Mouse rapsyn and mutant
yeast constructs were subcloned into pGBT10. For mam-
malian cell expression, rapsyn was subcloned between
Hind III and Xha I sites in pKH3, and between BamH I
A ternary complex of AChR, rapsyn, and α-actinin Figure 3
A ternary complex of AChR, rapsyn, and α-actinin. (A) Live C2C12 myotubes were incubated with B-BTX for 2 hr at 
4°C. Surface receptors were purified by streptavidin-coupled agarose beads. AChR-associated proteins were probed with anti-
bodies specific for α-actinin and the AChR β-subunit. (B) Quantitation of blot. The amount of α-actinin associated with surface 
AChRs was increased upon in agrin-stimulated myotubes. Data represent mean ± SEM of three experiments. **, p < 0.01, two-
tailed Student's paired t test. (C) α-Actinin was not associated with AChRs in rapsyn -/- myotubes. Control and rapsyn mutant 
myotubes were treated with agrin. AChRs were labeled by B-BTX and probed for α-actinin.Molecular Brain 2008, 1:18 http://www.molecularbrain.com/content/1/1/18
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Repression of α-actinin expression impaired agrin-induced AChR clustering Figure 4
Repression of α-actinin expression impaired agrin-induced AChR clustering. (A) HEK293 cells were transfected 
with GFP-α-actinin along with indicated miR-RNAi constructs of α-actinin. Thirty-six hours after transfection, cell were lyzed 
and resulting lysates were immunoblotted with antibodies against GFP. miR-actinin791 showed the strongest inhibition of α-
actinin expression. (B) Young C2C12 myotubes were transfected with the control vector or miR-RNA. After 24 hrs the myo-
tubes were treated with agrin for 18 hr. AChR clusters were examined in myotubes expressing GFP that was encoded by the 
miR-RNAi parental vector. Agrin-induced AChR clusters were reduced in myotubes expressing miR-actinin791, but not miR-
control encoding a scrambled sequence. Bar, 20 μm. (C) Quantitative analysis of data in (B). Data were presented as mean ± 
SEM, n = 20 each group; **, P < 0.01.Molecular Brain 2008, 1:18 http://www.molecularbrain.com/content/1/1/18
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and EcoR I sites in pEF6/myc-his (Invitrogen). Rapsyn
mutants were constructed with Quickchange Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA). Mammalian α-
actinin plasmids were generous gifts from Dr. A. Woods
(University of Alabama at Birmingham) and Dr. W. Hsu
(National Defense Medical Center, Taiwan). The miRNAi
entry vector was generated by the BLOCK-iT RNAi Expres-
sion System (Invitrogen) according to the manufacturer's
instruction. The sequence for mouse α-actinin 2 was ana-
lyzed by a program provided by Invitrogen; four
sequences were picked and cloned into pcDNA6.2-GW/
EmGFP-miR to yield pcDNA6.2-GW/EmGFP-miR-α-
actinin. The oligonucleotide sequences for miRNAi con-
structs were as follows: miRactinin331, 5'-TGC TGA ATA
Disruption of the rapsyn-α-actinin interaction by Abl inhibition and cholinergic stimulation Figure 5
Disruption of the rapsyn-α-actinin interaction by Abl inhibition and cholinergic stimulation. (A) C2C12 myotubes 
were treated with agrin in the presence of different concentrations of STI-571. The interaction between rapsyn and α-actinin 
was characterized as in Fig. 2. (B) Quantification of (A). Data represent mean ± SEM of three experiments. **, p < 0.01, two-
tailed Student's paired t test. (C) C2C12 myotubes were treated with or without agrin for 18 hr. After washing, agrin-treated 
myotubes were incubated with 10 μM carbachol. The carbachol treatment significantly decreased the rapsyn-α-actinin interac-
tion not only compared to agrin-treated but also untreated myotubes. (D) Quantification of (C). Data represent mean ± SEM 
of three experiments. **, p < 0.01, by two-tailed Student's paired t test.Molecular Brain 2008, 1:18 http://www.molecularbrain.com/content/1/1/18
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GAT ACC AGC TTC ACT CCG TTT TGG CCA CTG ACT
GAC GGA GTG AAT GGT ATC TAT T (forward); 5'-CCT
GAA TAG ATA CCA TTC ACT CCG TCA GTC AGT GGC
CAA AAC GGA GTG AAG CTG GTA TCT ATT C (reverse).
miRactinin791 5'-TGC TGT ACA TAT TCT GTT AGC TGC
TGG TTT TGG CCA CTG ACT GAC CAG CAG CTC AGA
ATA TGT A (forward); 5'-CCT GTA CAT ATT CTG AGC
TGC TGG TCA GTC AGT GGC CAA AAC CAG CAG CTA
ACA GAA TAT GTA C (reverse). miRactinin1096 5'-TGC
TGA GCA ATG TCC GAC ACC ATC TTG TTT TGG CCA
CTG ACT GAC AAG ATG GTC GGA CAT TGC T' (for-
ward); 5'-CCT GAG CAA TGT CCG ACC ATC TTG TCA
GTC AGT GGC CAA AAC AAG ATG GTG TCG GAC ATT
GCT C (reverse). miRactinin2330 5'-TGC TGA AAT GAG
GCA GGC TCT GAA ATG TTT TGG CCA CTG ACT GAC
ATT TCA GAC TGC CTC ATT T (forward); 5'-CCT GAA
ATG AGG CAG TCT GAA ATG TCA GTC AGT GGC CAA
AAC ATT TCA GAG CCT GCC TCA TTT C (reverse).
miRactinin2371 5'-TGC TGA ATG CGG GCA AAT TCA
GCT TCG TTT TGG CCA CTG ACT GAC GAA GCT GAT
TGC CCG CAT T (forward); 5'-CCT GAA TGC GGG CAA
TCA GCT TCG TCA GTC AGT GGC CAA AAC GAA GCT
GAA TTT GCC CGC ATT C (reverse). The numbers in the
miRNA constructs indicate the start of targeted nucleotide
sequences of the α-actinin 2 mouse gene.
Anti-α-actinin antibody was from Upstate (Charlottes-
ville, VA); and fluorescein-conjugated cholera toxin B sub-
unit (FITC-CTX) was from Sigma (St. Louis, MO). Rabbit
anti-rapsyn antibody was generated using GST-fusion pro-
tein containing N-terminal fragment of mouse rapsyn.
Myc and HA antibodies were from Santa Cruz. Anti-β-
AChR antibody (mAb124) was a gift from Dr. J. Lind-
strom (University of Pennsylvania Medical School, Phila-
delphia, PA). Interferon-gamma was from BioSource
(Camarillo, CA). α-Bungarotoxin (α-BTX), biotin conju-
gated α-BTX (B-BTX), and Alexa Fluor 594-conjugated α-
BTX were from Invitrogen (Eugene, OR). Neural agrin was
prepared as described previously [31,52,68]. Agrin treat-
ment was at 10 ng/ml for 18 hr which induced AChR clus-
ters.
Cell culture
C2C12 mouse muscle cells were maintained in a nutrient-
rich growth medium containing DMEM supplemented
with 2 mM L-glutamine, 20% fetal bovine serum, 0.5%
chicken embryo extract, and 100 U/ml penicillin at 37°C
in an atmosphere of 5% CO2 and 95% humidity [31,68].
Differentiation was induced when myoblasts were at 70%
confluence by switching to the differentiation medium,
DMEM supplemented with 4% horse serum, and 2 mM L-
glutamine. Rapsyn -/- (clone 11–71) muscle cells were
generously provided by Dr. Christian Fuhrer (University
of Zurich, Zurich, Switzerland), and cultured as described
previously [31,69]. Briefly, cells were maintained in the
same basic medium as C2C12 cells, with an additional 4
U/ml interferon. These cells were then grown on dishes
coated with 0.2% gelatin and maintained at 33°C with
5% CO2. To induce fusion, confluent cells were cultured
in C2C12 fusion medium at 37°C, 5% CO2. In all exper-
iments, the medium was replaced every day. HEK 293
cells were maintained as previously described [70].
Briefly, cells were maintained in a nutrient-rich growth
medium containing DMEM supplemented with 2 mM L-
glutamine, 10% fetal bovine serum, and 100 U/ml peni-
cillin at 37°C in an atmosphere of 5% CO2 and 95%
humidity. Transient transfection of cells was performed
with the standard calcium phosphate technique or with
lipofectamine 2000 according to the instructions of the
manufacturer (Invitrogen, Carlsbad, CA).
Immunoprecipitation, immunoblotting, and in vitro 
protein interactions
C2C12 myotubes or HEK 293 cells were rinsed twice with
ice-cold PBS, solubilized for 15 min on ice in lysis buffer,
containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1%
NP40, and .5% sodium deoxycholate supplemented with
protease inhibitor coctail. Lysates were then centrifuged at
12,000 rpm for 10 min, and the supernatants were incu-
bated with antibodies against rapsyn [68] or Myc at 4°C
followed by protein A or protein G agarose beads respec-
tively. To isolate surface AChRs, intact myotubes were
incubated with biotin-conjugated α-BTX for 2 hr at 4°C.
After washing, cells were lysed, and incubated with
streptavidin-coupled agarose beads for 6 hr at 4°C
[21,71]. After centrifugation, beads were washed twice
with lysis buffer followed by two washes with a high salt
lysis buffer and two times with a low salt lysis buffer.
Bound proteins were eluted with SDS sample buffer and
subjected to SDS-PAGE. Proteins resolved on SDS-PAGE
were transferred to nitrocellulose Portran membranes
(Schleicher and Schuell, Keene, NH), which were incu-
bated at room temperature for 1 hr in blocking buffer
(TBS with 0.1% Tween 20 and 5% milk), followed by an
incubation with the necessary antibodies at 4°C over-
night. After washing three times for 15 min each with TBS
with 0.1% Tween 20, the blots were incubated with horse-
radish peroxidase-conjugated secondary antibody (Amer-
sham Biosciences) or with Alexa Fluor 680-labeled anti-
mouse IgG antibody (1:5000; Invitrogen, Eugene, OR),
and IRDye 800-labeled anti-rabbit IgG antibody (1:3000;
Rockland Immunochemicals, Gilbertsville, PA). Immu-
noreactive bands were then visualized using enhanced
chemiluminescence substrate (Pierce, Rockford, IL) or the
Odyssey imaging system (LI-COR, Lincoln, NE) following
the manufacturer's protocols. In some experiments, after
visualizing an immunoreactive protein, the nitrocellulose
filter was incubated in a buffer containing 62.5 mM Tris/
HCl, pH 6.7, 100 mM β-mercaptoethanol, and 2% SDS at
50°C for 30 min, washed with TBS with 0.1% Tween 20Molecular Brain 2008, 1:18 http://www.molecularbrain.com/content/1/1/18
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at room temperature for 1 hr, and reblotted with different
antibodies. For quantitative analysis, films were scanned
with an Epson 1680 scanner, and the captured image was
analyzed with NIH Image software or the Odyssey imag-
ing system (LI-COR, Lincoln, NE) following the manufac-
turer's protocols.
α-Actinin 2 GST-fusion proteins were produced in BL21,
purified, and immobilized on glutathione sepharose 4B
beads (Amersham Pharmacia). They were then incubated
with lysates from HEK293 cells transfected with HA-rap-
syn. Bead-associated proteins were subjected to SDS-
PAGE and immunoblotting analysis. To assay the direct
interaction between rapsyn and α-actinin, [35S]-labeled
rapsyn was generated by in vitro translation in the pres-
ence of [35S]-labeled methionine using TnT T7/SP6 Cou-
pled Reticulocyte Lysate System (Promega, L5020) [53].
[35S]-labeled rapsyn was then incubated with immobi-
lized GST-α-actinin constructs in the binding buffer (25
mM HEPES, 1 mM DTT, 0.5% Triton X-100,150 mM NaCl
and protease inhibitors, pH7.5) for 2 hr at 4°C on a rota-
tor. After washing with PBS/0.1% Tween 20, bound [35S]-
labeled proteins were resolved on SDS-PAGE and sub-
jected to autoradiogram.
AChR clustering assays
Fully differentiated C2C12 myotubes, either control or
treated, were incubated with soluble recombinant agrin to
induce AChR clusters as described previously [31,68].
After fixation in 2% PFA for 30 min, cells were incubated
with Alexa 594-conjugated α-BTX for 60 min to label
AChR clusters. Myotube segments (200 μm in length)
were viewed at 40× magnification with a Nikon (Tokyo,
Japan) Optiphot microscope equipped with phase and
epifluorescence optics; and the number of AChR aggre-
gates was counted. AChR clusters with an axis >4 μm were
counted in 10 fields of each dish. In some experiments,
young myotubes (in differentiation medium for 2 days)
were transfected with indicated constructs using the lipo-
fectamine 2000 kit according to the manufacturer's
instruction (Invitrogen, Carlsbad, CA). 24–36 hr later,
transfected myotubes were subjected to AChR cluster
assays and viewed under a Zeiss confocal laser scanning
microscope (LSM 510 META 3.2).
Abbreviations
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specific receptor tyrosine kinase.
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